Research and development - Press Releases

Date	Title	Company
06-May-2021	F-star Therapeutics, Inc. Announces Proposed Public Offering of Common Stock	F-star Therapeutics
06-May-2021	Evotec launches "beLAB1407" to accelerate translational research from the UK's academic life science ecosystem in collaboration with Bristol Myers Squibb	Evotec
06-May-2021	FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis	Amgen
05-May-2021	Evotec and the GCKD study enter into strategic collaboration to build a unique molecular patient database	Evotec
05-May-2021	Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe	Lilly
04-May-2021	Beckman Coulter is first diagnostics company to offer workflow Automation specifically for Mid-volume Laboratories	Beckman Coulter
04-May-2021	Global Preeclampsia Laboratory Testing Market Leans on Awareness; Fairfield Market Research Projects over 10% Growth by 2025	Fairfield Market Research
04-May-2021	Pharmaceutical Intermediate Market projected to reach US$ 37,290.33 million by 2028 \| Codexis, chiracon, Vertellus Holdings, Lianhe Chemical Technology,	theinsightpartners
04-May-2021	Medical Cannabis Market Hits US$ 49,116.4 million by 2028 and to grow at a CAGR of 23.9% - Aphria, Aurora Cannabis, VIVO Cannabis, Tilray, CANVORY	theinsightpartners
30-Apr-2021	Global Genetic Virus Vector Industry Research Report, Growth Trends and Competitive Analysis 2020-2027	Lexis Business Insights
30-Apr-2021	Global Vaccine Bottle Industry Research Report, Growth Trends and Competitive Analysis 2020-2027	Lexis Business Insights
29-Apr-2021	Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT study to Investigate the T Cell Response and COVID vaccination in Ethnic Minority Groups.	Oxford Immunotec
29-Apr-2021	US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for previously untreated metastatic bladder cancer	Roche
29-Apr-2021	IQVIA Announces Connected Intelligence™	IQVIA
29-Apr-2021	Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022	Moderna
29-Apr-2021	Biogen Provides Regulatory Update on the Supplemental Biologic License Application (sBLA) for Subcutaneous Administration of TYSABRI® (natalizumab)	Biogen
28-Apr-2021	PARADIGM4 UNVEILS NEW ANALYTICAL DEVELOPMENT DATA MANAGEMENT TOOL TO UNLOCK ALLOTROPE DATA FORMAT ‘TREASURE TROVE’	Paradigm4
28-Apr-2021	Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer	Takeda
28-Apr-2021	Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19	Merck
28-Apr-2021	Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people	Roche